Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Regorafenib Treatment for Recurrent Glioblastoma Beyond Bevacizumab-Based Therapy: A Large, Multicenter, Real-Life Study.
Cancers (Basel). 2024 Dec 27;17(1):46. doi: 10.3390/cancers17010046.
Cancers (Basel). 2024.
PMID: 39796675
Free PMC article.
Efficacy and prognostic factors of anti-PD1 and nivolumab-ipilimumab therapy in advanced melanoma patients resistant to prior ICI treatment.
Acar C, Yüksel HÇ, Şahin G, Açar FP, Tünbekici S, Çelebi G, Karaca B.
Acar C, et al. Among authors: yuksel hc.
Discov Oncol. 2024 Dec 20;15(1):813. doi: 10.1007/s12672-024-01702-w.
Discov Oncol. 2024.
PMID: 39704850
Free PMC article.
Item in Clipboard
Exploring the Frequency and Risk Factors of Hyperprogressive Disease in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors.
Acar C, Yüksel HÇ, Şahin G, Açar FP, Karaca B.
Acar C, et al. Among authors: yuksel hc.
Curr Oncol. 2024 Oct 18;31(10):6343-6355. doi: 10.3390/curroncol31100472.
Curr Oncol. 2024.
PMID: 39451776
Free PMC article.
Item in Clipboard
Rare immune-related adverse effect of pembrolizumab: pulmonary hypertension.
Acar C, Sahin G, Yüksel HÇ, Karaca B.
Acar C, et al. Among authors: yuksel hc.
J Chemother. 2024 May 8:1-6. doi: 10.1080/1120009X.2024.2349858. Online ahead of print.
J Chemother. 2024.
PMID: 38717744
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.